|
|
Exchange: |
OTC Bulletin Board |
Security
Type: |
Common |
Shares
Out: |
29,950,000 |
Market
Cap: |
72.78(M) |
Last
Volume: |
42,300 |
Avg
Vol: |
42,185 |
52
Week Range: |
$2.415 - $5.02 |
|
Level
I Sector: |
Information Technology |
Level
II Sector: |
Computer Hardware |
Level
III Sector: |
Computer Peripherals |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : 9.1 |
Insider 6 Months : 9.1 |
Insider 3/6 Months : 18.2 |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Anixa Biosciences is a biotechnology company developing therapies and vaccines that are focused on unmet needs in oncology and infectious disease. Co.'s therapeutics programs include the development of a chimeric endocrine receptor T-cell therapy, a form of chimeric antigen receptor T-cell technology, initially focused on treating ovarian cancer and the discovery and development of anti-viral drug candidates for the treatment of Coronavirus disease 2019 focused on inhibiting certain protein functions of the virus. Co.'s vaccine programs include the development of a vaccine against triple negative breast cancer as well other forms of breast cancer and a vaccine against ovarian cancer.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
55,009 |
55,009 |
60,509 |
60,509 |
Total Buy Value |
$182,130 |
$182,130 |
$202,150 |
$202,150 |
Total People Bought |
3 |
3 |
4 |
4 |
Total Buy Transactions |
3 |
3 |
4 |
4 |
Total Shares Sold |
0 |
0 |
11,800 |
11,800 |
Total Sell Value |
$0 |
$0 |
$42,126 |
$42,126 |
Total People Sold |
0 |
0 |
1 |
1 |
Total Sell Transactions |
0 |
0 |
1 |
1 |
End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Bowers Anthony |
Director |
|
2004-06-24 |
4 |
OE |
$0.34 |
$15,800 |
D/D |
40,000 |
214,300 |
|
- |
|
Krusos Denis A |
Chief Executive Officer |
|
2004-06-07 |
5 |
GD |
$0.00 |
$0 |
D/D |
100,000 |
1,849,310 |
|
- |
|
Krusos Denis A |
Chief Executive Officer |
|
2004-04-02 |
4 |
A |
$0.00 |
$0 |
D/D |
135,000 |
6,727,600 |
|
- |
|
Krusos Denis A |
Chief Executive Officer |
|
2004-01-13 |
5 |
GD |
$0.00 |
$0 |
D/D |
300,000 |
1,849,310 |
|
- |
|
354 Records found
|
|
Page 15 of 15 |
|
|